MEX3A Promotes Development and Progression of Breast Cancer Through Regulation of PIK3CA

Xianbiao Shi,Yulu Sun,Yin Zhang,Wei Wang,Jiahan Xu,Yinan Guan,Yitao Ding,Yongzhong Yao
DOI: https://doi.org/10.1016/j.yexcr.2021.112580
IF: 4.145
2021-01-01
Experimental Cell Research
Abstract:Breast cancer has been identified as the most common malignant tumors among women and the morbidity of breast cancer is still increasing rapidly. MEX3A possesses important functions in the regulation of mRNAs and may be involved in a variety of human diseases including cancer, whose relationship with breast cancer is still not clear. In this study, MEX3A was identified as a potential promotor in breast cancer, whose expression was strongly higher in breast cancer tissues than normal tissues. The in vitro experiments showed that MEX3A is capable of promoting the development of breast cancer through stimulating cell proliferation, inhibiting cell apoptosis, arresting cell cycle and promoting cell migration. The functions of MEX3A were also verified in vivo. Furthermore, a combination of genechip analysis and Ingenuity pathway analysis (IPA) identified PIK3CA as a potential downstream target of MEX3A, knockdown of which executes similar inhibitory effects on breast cancer and could alleviate MEX3A-induced progression of breast cancer. In conclusion, our study unveiled, as the first time, MEX3A as a tumor promotor for breast cancer, whose function was carried out probably through the regulation of PIK3CA.
What problem does this paper attempt to address?